| Name | Title | Contact Details |
|---|
Based in Knoxville, Tenn., Priority Ambulance provides the highest level of clinical excellence in emergency and nonemergency medical care to the communities it serves. Throughout its national service area, approximately 2,000 highly trained paramedics and EMTs staff a fleet of approximately 400 state-of-the-art vehicles with the latest medical equipment and technology. Priority Ambulance`s community of companies operates under trusted local brands providing medical transport options in nine states. The Priority Ambulance company partners include Shoals Ambulance in Alabama; Maricopa Ambulance in Arizona; Puckett EMS in Georgia and Southeast Tennessee; Central EMS in Georgia; Seals Ambulance in Indiana; Kunkel Ambulance in Upstate New York; Trans Am Ambulance in western New York and Northwestern Pennsylvania; Medshore Ambulance in South Carolina; and Priority Ambulance in East Tennessee. Priority Ambulance also serves Baptist Memorial Health Care facilities in West Tennessee and Mississippi under the Baptist brand.
With more than 300 physicians and 3,600 employees – nearly 1,000 of which are registered nurses – Kaweah Delta Health Care District provides the people living and working in California`s bustling Central Valley with access to high-quality health care just minutes from home. Located in Tulare County, the heart of the state`s rural Central Valley, Kaweah Delta is a 581-bed, eight-campus healthcare district established in 1961 and governed by a five-member board of directors.
Northern Nevada Medical Center is a Sparks, NV-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Signal Genetics is a commercial stage, molecular diagnostic company focused on providing innovative diagnostic services that help physicians make better-informed decisions concerning the care of their patients suffering from cancer. The company was founded in April 2010 after becoming the exclusive licensee to the world-renowned research on multiple myeloma (MM) performed at the University of Arkansas for Medical Sciences (UAMS). Signal Genetics’ flagship product - MyPRS (Myeloma Prognostic Risk Signature) is based upon more than two decades of clinical research on nearly 10,000 MM patients who received their care at UAMS. Signal Genetics offer the MyPRS test out of its state-of-the-art, CLIA certified reference laboratory located in Little Rock, AR. The company is dedicated to making its extensively validated diagnostic services available to all patients who need them. The mission of Signal Genetics is to develop, validate and deliver innovative diagnostic services that enable better patient-care decisions.
St Boniface General Hospital is a Winnipeg, MB-based company in the Healthcare, Pharmaceuticals, & Biotech sector.